I now see a point in the capital raising. I guess if they do...

I now see a point in the capital raising. I guess if they do have a failure they want to ensure they have enough cash to get another project in the pipeline to a stage which generates sufficient market interest so they can raise more capital again at a decent price. It would blow for the current shareholders if they blew all their money chasing the pain and fat drugs and they flopped, leaving the company with no drugs near production and no cash!!

Cheers,
Nick